Age-related Variability of the Efficacy and Tolerability of Alternative Pituitary Suppression Regimens in Follicular Stimulation for Assisted Reproduction Purposes. A Randomised, Prospective, Multi-centre Clinical Trial.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Recombinant follicle-stimulating hormone; Urofollitropin
- Indications Infertility
- Focus Therapeutic Use
- 26 Mar 2012 Biomarkers information updated
- 14 Mar 2012 Planned End Date changed from 1 Oct 2012 to 1 Apr 2013 as reported by ClinicalTrials.gov.
- 24 Apr 2010 New trial record